PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1403512
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1403512
Myomectomy Market Forecasts to 2030 - Global Analysis By Product, Type, End User and By Geography
According to Stratistics MRC, the Global Myomectomy Market is accounted for $756.59 million in 2023 and is expected to reach $1580.73 million by 2030 growing at a CAGR of 11.1% during the forecast period. A myomectomy is a surgical procedure aimed at removing noncancerous growths known as uterine fibroids from the muscular wall of the uterus. It is a viable alternative for women who want to avoid a hysterectomy or maintain their fertility. Furthermore, a number of techniques, such as open surgery, laparoscopy, and robotic-assisted surgery, can be used to carry out this procedure.
According to the Society for Women's Health Research report, in the U.S. approximately 26 million women ages 15-50 have uterine fibroids.
Market Dynamics:
Driver:
Growing prevalence of uterine fibroids
Uterine fibroids are common benign tumours affecting a substantial number of women, particularly during their reproductive years. For instance, according to the Illinois Department of Public Health, around 77% of women of childbearing age may have uterine fibroids. Therefore, as more women have uterine fibroids diagnoses, there is a growing need for efficient treatment solutions to manage the resulting symptoms. Furthermore, minimally invasive techniques such as laparoscopy and robotic-assisted surgery are gaining popularity in myomectomy. This growing prevalence of uterine fibroids fuels the demand for myomectomy procedures, propelling the market's expansion
Restraint:
Fertility concerns
Myomectomy has the potential to affect fertility ability, even if the aim is to protect fertility by removing uterine fibroids. The surgical procedure, especially if multiple or large fibroids are removed, might lead to scarring or alterations in the uterus, potentially affecting reproductive capabilities. Women who wish to have children in the future are influenced by their concern about possible issues with their fertility after a myomectomy. This affects their decision-making process regarding treatment and may even restrict the market's expansion.
Opportunity:
Rising demand for minimally invasive procedures
Patients increasingly favour minimally invasive techniques like laparoscopic or robotic-assisted myomectomy due to reduced recovery times, less scarring, and a quicker return to daily activities. This growing preference aligns with the desire for effective yet less invasive treatments, especially among women seeking fertility preservation. Furthermore, healthcare providers offering these advanced procedures can attract more patients seeking myomectomy, addressing the rising demand for minimally invasive options and potentially expanding the market.
Threat:
Non-surgical alternatives
Advanced non-surgical treatments like uterine artery embolisation (UAE) or focused ultrasound surgery (FUS) offer effective options for treating uterine fibroids without surgery. The availability and increasing success rates of these non-surgical treatments pose a challenge to the traditional myomectomy market, potentially reducing the demand for surgical procedures and impacting the market's growth by offering compelling alternatives for fibroid management without surgical interventions.
COVID-19 Impact
The COVID-19 epidemic severely impacted women's healthcare and the market for myomectomy procedures. It caused delays in diagnosis and treatment, as well as the postponement of non-urgent treatments in the medical field. Also, interruptions in the supply chain impacted the accessibility of medical supplies required for myomectomy operations. In addition, hospitals diverted funds for COVID-19 therapy, which affected the focus on non-urgent medical operations. Consequently, COVID-19 limited the growth of the myomectomy market.
The laparoscopic myomectomy segment is expected to be the largest during the forecast period
The laparoscopic myomectomy segment is estimated to hold the largest share. Laparoscopic myomectomy involves a minimally invasive surgical procedure to remove uterine fibroids. This technique utilizes small incisions through which specialized instruments and a laparoscope are inserted, providing a magnified view of the uterus. Moreover, it offers benefits like shorter hospital stays, faster recuperation, and reduced postoperative complications. With increasing patient preference for minimally invasive options and advancements in laparoscopic techniques, this segment continues to gain traction as a preferred method for treating uterine fibroids.
The hospitals & clinics segment is expected to have the highest CAGR during the forecast period
The hospitals & clinics segment is anticipated to have lucrative growth during the forecast period. Hospitals and clinics equipped with advanced medical infrastructure and skilled healthcare professionals cater to patients seeking various treatment options for uterine fibroids. They offer comprehensive diagnostic evaluations, surgical expertise, and postoperative care, addressing patient needs with diverse surgical approaches such as laparoscopic, robotic-assisted, or open myomectomy procedures. In addition, hospitals and clinics play a pivotal role in delivering specialised care, contributing significantly to the accessible and comprehensive management of uterine fibroids through myomectomy.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period owing to the increasing number of women suffering from uterine disorders and the rising investment in the surgical device industry by key players in developing economies. China and Japan have played a significant role in the market expansion for myomectomy procedures. The supply of highly skilled medical personnel, including surgeons and gynaecologists, as well as the rising need for technologically sophisticated medical technologies, such as gene chips, for research purposes, are the main reasons for this growth.
Region with highest CAGR:
North America is expected to witness profitable growth over the projection period, due to the rising prevalence of uterine fibroid and technological advancements in myomectomy procedures. According to the data updated by the United States Office on Women's Health in February 2021, it was estimated that about 20 percent to 80 percent of women developed fibroids by the time they reached age 50. Women in their 40s and early 50s are most likely to develop uterine fibroids. While not all fibroids cause symptoms, those who do frequently find living with their fibroids to be difficult. Thus, the high burden of uterine fibroids in the United States is expected to boost market growth.
Key players in the market:
Some of the key players in the Myomectomy Market include Medtronic, Conmed Corporation, Stryker Corporation, Insightec, Hologic, Inc, Cooper Surgical Inc, Intuitive Surgical, Braun Melsungen AG, Minerva Surgical Inc, Johnson And Johnson Services Inc., Karl Storz, Boston Scientific Corporation, General Electric Company, F. Hoffmann-La Roche Ltd, Richard Wolf Medical Instruments, Siemens, Bayer, AbbVie Inc. and Halt Medical, Inc.
Key Developments:
In November 2022, Olympus announced the market launch of the moresolution Power Morcellator, manufactured by TROKAMED GmbH and available in the United States through a distribution agreement with Olympus America, Inc. The moresolution Morcellator is designed for advanced gynecologic procedures with large, calcified tissue specimens. Olympus's pneumoLiner and the moresolution Morcellator can provide select patients with a laparoscopic surgical option.
In April 2022, Ethicon, part of Johnson & Johnson MedTech, launched the ENSEAL X1 Straight Jaw Tissue Sealer. The ENSEAL X1 Straight Jaw is indicated for use in open and laparoscopic general, gynecological, and urologic procedures.
Products Covered:
- Laparoscopic Power Morcellators
- Laparoscopic Sealer
- Harmonic Scalpel
- Other Products
Types Covered:
- Abdominal Myomectomy
- Laparoscopic Myomectomy
- Hysteroscopic Myomectomy
- Robotic Myomectomy
End Users Covered:
- Ambulatory Surgical Centers
- Hospitals & Clinics
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Myomectomy Market, By Product
- 5.1 Introduction
- 5.2 Laparoscopic Power Morcellators
- 5.3 Laparoscopic Sealer
- 5.4 Harmonic Scalpel
- 5.5 Other Products
6 Global Myomectomy Market, By Type
- 6.1 Introduction
- 6.2 Abdominal Myomectomy
- 6.3 Laparoscopic Myomectomy
- 6.4 Hysteroscopic Myomectomy
- 6.5 Robotic Myomectomy
7 Global Myomectomy Market, By End User
- 7.1 Introduction
- 7.2 Ambulatory Surgical Centers
- 7.3 Hospitals & Clinics
- 7.4 Other End Users
8 Global Myomectomy Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Medtronic
- 10.2 Conmed Corporation
- 10.3 Stryker Corporation
- 10.4 Insightec
- 10.5 Hologic, Inc
- 10.6 Cooper Surgical Inc
- 10.7 Intuitive Surgical
- 10.8 Braun Melsungen AG
- 10.9 Minerva Surgical Inc
- 10.10 Johnson And Johnson Services Inc.
- 10.11 Karl Storz
- 10.12 Boston Scientific Corporation
- 10.13 General Electric Company
- 10.14 F. Hoffmann-La Roche Ltd
- 10.15 Richard Wolf Medical Instruments
- 10.16 Siemens
- 10.17 Bayer
- 10.18 AbbVie Inc.
- 10.19 Halt Medical, Inc.
List of Tables
- Table 1 Global Myomectomy Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Myomectomy Market Outlook, By Product (2021-2030) ($MN)
- Table 3 Global Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
- Table 4 Global Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
- Table 5 Global Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
- Table 6 Global Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
- Table 7 Global Myomectomy Market Outlook, By Type (2021-2030) ($MN)
- Table 8 Global Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
- Table 9 Global Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
- Table 10 Global Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
- Table 11 Global Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
- Table 12 Global Myomectomy Market Outlook, By End User (2021-2030) ($MN)
- Table 13 Global Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 14 Global Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 15 Global Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 16 North America Myomectomy Market Outlook, By Country (2021-2030) ($MN)
- Table 17 North America Myomectomy Market Outlook, By Product (2021-2030) ($MN)
- Table 18 North America Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
- Table 19 North America Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
- Table 20 North America Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
- Table 21 North America Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
- Table 22 North America Myomectomy Market Outlook, By Type (2021-2030) ($MN)
- Table 23 North America Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
- Table 24 North America Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
- Table 25 North America Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
- Table 26 North America Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
- Table 27 North America Myomectomy Market Outlook, By End User (2021-2030) ($MN)
- Table 28 North America Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 29 North America Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 30 North America Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 31 Europe Myomectomy Market Outlook, By Country (2021-2030) ($MN)
- Table 32 Europe Myomectomy Market Outlook, By Product (2021-2030) ($MN)
- Table 33 Europe Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
- Table 34 Europe Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
- Table 35 Europe Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
- Table 36 Europe Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
- Table 37 Europe Myomectomy Market Outlook, By Type (2021-2030) ($MN)
- Table 38 Europe Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
- Table 39 Europe Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
- Table 40 Europe Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
- Table 41 Europe Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
- Table 42 Europe Myomectomy Market Outlook, By End User (2021-2030) ($MN)
- Table 43 Europe Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 44 Europe Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 45 Europe Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 46 Asia Pacific Myomectomy Market Outlook, By Country (2021-2030) ($MN)
- Table 47 Asia Pacific Myomectomy Market Outlook, By Product (2021-2030) ($MN)
- Table 48 Asia Pacific Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
- Table 49 Asia Pacific Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
- Table 50 Asia Pacific Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
- Table 51 Asia Pacific Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
- Table 52 Asia Pacific Myomectomy Market Outlook, By Type (2021-2030) ($MN)
- Table 53 Asia Pacific Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
- Table 54 Asia Pacific Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
- Table 55 Asia Pacific Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
- Table 56 Asia Pacific Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
- Table 57 Asia Pacific Myomectomy Market Outlook, By End User (2021-2030) ($MN)
- Table 58 Asia Pacific Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 59 Asia Pacific Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 60 Asia Pacific Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 61 South America Myomectomy Market Outlook, By Country (2021-2030) ($MN)
- Table 62 South America Myomectomy Market Outlook, By Product (2021-2030) ($MN)
- Table 63 South America Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
- Table 64 South America Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
- Table 65 South America Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
- Table 66 South America Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
- Table 67 South America Myomectomy Market Outlook, By Type (2021-2030) ($MN)
- Table 68 South America Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
- Table 69 South America Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
- Table 70 South America Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
- Table 71 South America Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
- Table 72 South America Myomectomy Market Outlook, By End User (2021-2030) ($MN)
- Table 73 South America Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 74 South America Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 75 South America Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 76 Middle East & Africa Myomectomy Market Outlook, By Country (2021-2030) ($MN)
- Table 77 Middle East & Africa Myomectomy Market Outlook, By Product (2021-2030) ($MN)
- Table 78 Middle East & Africa Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
- Table 79 Middle East & Africa Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
- Table 80 Middle East & Africa Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
- Table 81 Middle East & Africa Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
- Table 82 Middle East & Africa Myomectomy Market Outlook, By Type (2021-2030) ($MN)
- Table 83 Middle East & Africa Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
- Table 84 Middle East & Africa Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
- Table 85 Middle East & Africa Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
- Table 86 Middle East & Africa Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
- Table 87 Middle East & Africa Myomectomy Market Outlook, By End User (2021-2030) ($MN)
- Table 88 Middle East & Africa Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 89 Middle East & Africa Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 90 Middle East & Africa Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
